Bullock Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$288K Sell
796
-22
-3% -$7.53K 0.12% 146
2026
Q1
$289K Sell
818
-63
-7% -$22.5K 0.14% 133
2025
Q4
$288K Sell
881
-45
-5% -$14.3K 0.14% 134
2025
Q3
$277K Buy
926
+1
+0.1% +$290 0.14% 129
2025
Q2
$269K Buy
925
+24
+3% +$6.8K 0.14% 124
2025
Q1
$276K Sell
901
-775
-46% -$229K 0.15% 120
2024
Q4
$437K Sell
1,676
-834
-33% -$247K 0.25% 86
2024
Q3
$804K Sell
2,510
-75
-3% -$24.5K 0.48% 52
2024
Q2
$804K Sell
2,585
-155
-6% -$45.5K 0.53% 44
2024
Q1
$776K Buy
+2,740
New +$802K 0.52% 46

Other funds holding AMGN

Bullock Wealth Management's AMGN Position: Q2 2026 in Review

Bullock Wealth Management reduced its Amgen (AMGN) stake by 2.7% in Q2 2026, selling an estimated $7.53K and leaving 796 shares worth $288K. The position accounts for 0.12% of the portfolio, ranked #146.

Bullock Wealth Management first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $804K in Q3 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bullock Wealth Management held 796 shares of Amgen worth $288K as of Q2 2026.
  • Bullock Wealth Management sold 22 Amgen shares in Q2 2026, an estimated $7.53K.
  • Amgen made up 0.12% of Bullock Wealth Management's portfolio in Q2 2026, its #146 holding.
  • Bullock Wealth Management first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • Bullock Wealth Management's Amgen position peaked at $804K in Q3 2024.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.